OGT and Familial prostate cancer: In our experiments, we noted that co-treatment of prostate cancer cells with vitamin B5 and CDK9 inhibitor induces combinatorial antiproliferative effects and further increased DNA damage, which were associated with decreased OGT expression (Fig. 4).